Financhill
Back

Catalyst Pharmaceuticals Quote, Financials, Valuation and Earnings

A 100% Win Rate In 2022

Click to see this exclusive sit-down interview
Buy
77

CPRX
Catalyst Pharmaceuticals

Last Price:
16.03
Seasonality Move:
12.04%

7 Day Trial

ALL ACCESS PASS

$ 7

Get Free, Instant Access To Today's Top Stocks List!

View this list for FREE now!

Catalyst Pharmaceuticals Price Quote

$16.03
-0.18 (-1.11%)
(Updated: March 23, 2023 at 4:10 PM ET)

Catalyst Pharmaceuticals Key Stats

Buy
77
Catalyst Pharmaceuticals (CPRX) is a Buy

Day range:
$16.18 - $16.74
52-week range:
$6.15 - $22.11
Dividend yield:
0%
P/E ratio:
21.61
P/S ratio:
8.41
P/B ratio:
5.7%

Volume:
1.7M
Avg. volume:
1.8M
1-year change:
95.54%
Market cap:
$1.7B
Revenue:
$214.2M
EPS:
$0.74

How Much Does Catalyst Pharmaceuticals Make?

Is Catalyst Pharmaceuticals Growing As A Company?

Catalyst Pharmaceuticals Stock Price Performance

What Is Catalyst Pharmaceuticals 52-Week High & Low?

Catalyst Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy Catalyst Pharmaceuticals?

Is Catalyst Pharmaceuticals Cash Flow Positive?

  • What Is CPRX Cash Flow From Operations?
    Cash flow from operations (TTM) is $116M
  • What Is Catalyst Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $1.7M
  • What Is Catalyst Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $9.2M

Catalyst Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    CPRX return on invested capital is 33.54%
  • What Is Catalyst Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is 28.44%
  • What Is CPRX Return On Equity?
    ROE is a measure of profitability and is 33.54%

Catalyst Pharmaceuticals Earnings Date & Stock Price

Catalyst Pharmaceuticals Competitors

Catalyst Pharmaceuticals Dividend Yield

Data Unavailable

Catalyst Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 144.44% 11.86%
Revenue: 58.6% 0.19%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 21.65
Upside from Last Price: 33.56%

Major Shareholders

  • How many CPRX shares are owned by institutional investors?
    131.8M CPRX shares are owned by institutional investors
  • How many CPRX shares are owned by insiders?
    8.4M CPRX shares are owned by insiders